ReviewJournal of neural transmission (Vienna, Austria : 1996)2026
The lifespan continuum of brain disorders: investigating links between neurodevelopmental and neurodegenerative disease-chicken or egg?
Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Is the Loss of Previously Acquired Skills a Feature of PACS1-, PACS2- and WDR37-Related Syndromes? A Systematized Narrative Review.International journal of molecular sciences · 2026Review
- Reduced glymphatic function in autism revealed by the diffusion tensor analysis along the perivascular space index.Journal of neural transmission (Vienna, Austria : 1996) · 2026Article
- Functional Pathological Features and Molecular Markers in Alzheimer's Disease.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasing evidence indicates that neurodevelopmental disorders, such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), may be linked to a higher risk of developing neurodegenerative diseases, including Parkinson’s disease (PD) and Alzheimer’s disease (AD), later in life. Traditionally, these conditions have been viewed as fundamentally different in their causes, symptoms, and progression. Neurodevelopmental disorders appear early in life, while neurodegenerative diseases usually develop later, often in older age. However, recent research is increasingly highlighting shared molecular mechanisms and pathophysiological features across these disorder groups. Notably, shared processes such as oxidative stress, chronic neuroinflammation, and metabolic dysregulation have emerged as key contributors. Understanding these convergences may open the door to novel, targeted therapeutic strategies. This review critically examines the current evidence supporting potential links between neurodevelopmental conditions such as ASD and ADHD, and neurodegenerative diseases like AD and PD. While some pathological and molecular data suggest overlapping mechanisms, the overall evidence remains mixed and, in many aspects, inconclusive. Although associations between neurodevelopmental disorders and an increased risk of neurodegenerative diseases appear compelling in certain studies, the precise etiological pathways underlying these relationships remain poorly understood. Comorbidities such as depression, chronic stress, metabolic disturbances, and lifestyle-related factors are likely to act as mediators, potentially amplifying vulnerability to cognitive decline, dementia, or parkinsonian features over time. To address these uncertainties, additional epidemiological and clinical research is needed to expand and validate the current evidence base and to clarify the potential links between neurodevelopmental and neurodegenerative conditions.
Indexed as
Identifiers
41493577What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.